ARA-C AND AMSA IN THE THERAPY OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA

被引：0
|
作者：
JAGER, U [1 ]
机构：
[1] VIENNA UNIV,MED KLIN 1,A-1010 VIENNA,AUSTRIA
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 1986年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：589 / 589
页数：1
相关论文
共 50 条
  • [31] Irinotecan (CPT-11) and cytarabine (Ara-C) in refractory acute myeloid leukemia (AML).
    Minderman, H
    O'Loughlin, KL
    Thomas, KJ
    Pixley, LA
    Wetzler, M
    Slack, JL
    Baer, MR
    LEUKEMIA, 2001, 15 (03) : 509 - 509
  • [32] LOW-DOSES OF ARA-C IN CHRONIC MYELOID-LEUKEMIA IN BLASTIC TRANSFORMATION
    DIRAIMONDO, F
    GUGLIELMO, P
    MILONE, G
    CACCIOLA, E
    GIUSTOLISI, R
    HAEMATOLOGICA, 1985, 70 (03) : 275 - 276
  • [33] SUCCESSFUL TREATMENT WITH LOW-DOSE ARA-C IN DENOVO ACUTE MYELOID-LEUKEMIA WITH TRILINEAGE MYELODYSPLASIA
    KAWANO, F
    NISHIMURA, Y
    TSUKAMOTO, A
    SATOH, M
    SANADA, I
    SHIDO, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1992, 55 (01) : 101 - 102
  • [34] INVIVO GROWTH AND ARA-C PHARMACOLOGICAL DETERMINANTS OF CLINICAL-RESPONSE IN ACUTE MYELOID-LEUKEMIA (AML)
    KARP, JE
    DONEHOWER, RC
    DOLE, GB
    ENTERLINE, J
    BURKE, PJ
    CELL AND TISSUE KINETICS, 1988, 21 (01): : 61 - 62
  • [35] PERTURBED CELL-GROWTH AND ARA-C PHARMACOLOGY IN ACUTE MYELOID-LEUKEMIA (AML) AT DIAGNOSIS AND AT RELAPSE
    KARP, JE
    DONEHOWER, RC
    DOLE, GB
    BURKE, PJ
    CELL AND TISSUE KINETICS, 1987, 20 (02): : 244 - 244
  • [36] DETECTION OF BLAST CELLS RESISTANT TO ARA-C IN ACUTE MYELOID-LEUKEMIA USING FLOW-CYTOMETRY
    LACOMBE, F
    BELLOC, F
    DUMAIN, P
    PUNTOUS, M
    CONYMAKHOUL, P
    BERNARD, P
    BOISSEAU, MR
    REIFFERS, J
    BULLETIN DU CANCER, 1995, 82 (05) : 349 - 356
  • [37] MIRROS: An ongoing randomized phase 3 trial of idasanutlin plus ARA-C in patients with relapsed or refractory acute myeloid leukemia.
    Montesinos, Pau
    Esteve, Jordi
    Konopleva, Marina
    Martinelli, Giovanni
    Ottmann, Oliver
    Rodriguez-Veiga, Rebeca
    Rollig, Christoph
    Wei, Andrew
    Vey, Norbert
    Chiu, Idy
    Monnet, Annabelle
    Ott, Marion Gabriele
    Fenaux, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] INTENSIVE POSTREMISSION THERAPY WITH ARA-C IN ADULTS WITH ACUTE MYELOID-LEUKEMIA - INITIAL RESULTS OF A CALGB PHASE-III TRIAL
    MAYER, RJ
    DAVIS, RB
    SCHIFFER, CA
    BERG, DT
    SARNO, E
    FREI, E
    LEUKEMIA, 1992, 6 : 66 - 67
  • [39] THERAPY OF REFRACTORY RELAPSED ACUTE MYELOID-LEUKEMIA AND BLAST CRISIS OF CHRONIC MYELOID-LEUKEMIA WITH THE COMBINATION OF CYTOSINE-ARABINOSIDE, TETRAHYDROURIDINE, AND CARBOPLATIN
    MARSH, JH
    KREIS, W
    BARILE, B
    AKERMAN, S
    SCHULMAN, P
    ALLEN, SL
    DEMARCO, LC
    SCHUSTER, MW
    BUDMAN, DR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 31 (06) : 481 - 484
  • [40] CURATIVE EFFECT AND SAFETY OF 2-CDA, ARA-C AND G-CSF COMBINED TREATMENT FOR RELAPSED REFRACTORY ACUTE MYELOID LEUKEMIA
    Zhang, Xiaoxiang
    Chen, Ying
    Shou, Lihong
    Yang, Jianghua
    ACTA MEDICA MEDITERRANEA, 2021, 37 (01): : 163 - 167
12345